Risk Factors for Functional Limitations in Patients with Long-standing Ankylosing Spondylitis

Overview

Journal Arthritis Rheum

Specialty Rheumatology

Date 2005 Oct 7

PMID 16208654

Citations 40

Authors

Michael M Ward

Michael H Weisman

John C Davis Jr

John D Reveille

Affiliations

Soon will be listed here.

Abstract

Objective: To identify risk factors for functional limitations in patients with ankylosing spondylitis (AS) of at least 20 years' duration.

Methods: Patients with AS for > or =20 years were enrolled in the cross-sectional component of the Prospective Study of Outcomes in AS. All patients had clinical evaluations and completed questionnaires on functional limitations and potential risk factors. Functional limitations were assessed using the Bath Ankylosing Spondylitis Functional Index (BASFI; score range 0-100, higher scores indicate more limitations) and the Health Assessment Questionnaire for the Spondylarthropathies (HAQS). Risk factors included demographic characteristics, duration of AS, smoking status, number of comorbid medical conditions, recalled level of recreational activity in teens and twenties, occupational physical activity throughout life (rated 1 = little, 2 = moderate, 3 = heavy, and weighted by the number of years in each job), and history of AS in a first-degree relative.

Results: The 326 patients (74% men) had a mean +/- SD age of 55.0 +/- 10.7 years, a mean duration of AS symptoms of 31.7 +/- 10.2 years, and a mean BASFI score of 40.7 +/- 25.6. BASFI scores increased with higher lifetime occupational physical activity (r = 0.31; P < 0.0001), the number of comorbid conditions (r = 0.25; P < 0.0001), and the duration of AS (r = 0.12; P = 0.04). BASFI scores were higher among current smokers compared with former/nonsmokers (55.5 versus 38.9; P = 0.0002), and among nonwhites compared with whites (49.9 versus 39.3; P = 0.02). In multivariable analyses, lifetime occupational physical activity, current smoking, education level, number of comorbid conditions, and family history were significantly associated with BASFI scores. The same risk factors were associated with the HAQS.

Conclusion: Functional limitations in patients with AS for >/=20 years are greater among those with a history of more physically demanding jobs, more comorbid conditions, and among smokers, and are less severe among those with higher levels of education and a family history of AS.

Citing Articles

Fast, Present and Future of the Concept of Spondyloarthritis.

Braun J Curr Rheumatol Rep. 2025; 27(1):15.

PMID: 39869233 DOI: 10.1007/s11926-024-01179-0.

Navigating the Factors Affecting Functional Impairment in Spondyloarthritis.

Maatallah K, Cherif I, Ferjani H, Nessib D, Boumaiza R, Kaffel D Sultan Qaboos Univ Med J. 2024; 24(2):235-242.

PMID: 38828242 PMC: 11139368. DOI: 10.18295/squmj.3.2024.023.

Physical function and sex differences in radiographic axial spondyloarthritis: a cross-sectional analysis on Bath Ankylosing Spondylitis Functional Index.

Hallstrom M, Klingberg E, Deminger A, Beckman Rehnman J, Geijer M, Forsblad-dElia H Arthritis Res Ther. 2023; 25(1):182.

PMID: 37749599 PMC: 10521572. DOI: 10.1186/s13075-023-03173-w.

Prediction of radiographic progression pattern in patients with ankylosing spondylitis using group-based trajectory modeling and decision trees.

Kang J, Lee T, Park S, Lee S, Koo B, Kim T Front Med (Lausanne). 2022; 9:994308.

PMID: 36341272 PMC: 9631932. DOI: 10.3389/fmed.2022.994308.

Treat-to-target in axial spondyloarthritis - what about physical function and activity?.

Braun J, Baraliakos X, Kiltz U Nat Rev Rheumatol. 2021; 17(9):565-576.

PMID: 34312518 DOI: 10.1038/s41584-021-00656-5.

References

Ward M . Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum. 2002; 46(1):223-31. DOI: 10.1002/1529-0131(200201)46:1<223::AID-ART498>3.0.CO;2-#. View

Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W . Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 2002; 359(9313):1187-93. DOI: 10.1016/s0140-6736(02)08215-6. View

Gorman J, Sack K, Davis Jr J . Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 2002; 346(18):1349-56. DOI: 10.1056/NEJMoa012664. View

Falkenbach A, Franke A, van Tubergen A, van der Linden S . Assessment of functional ability in younger and older patients with ankylosing spondylitis: performance of the bath ankylosing spondylitis functional index. Am J Phys Med Rehabil. 2002; 81(6):416-20. DOI: 10.1097/00002060-200206000-00004. View

Chorus A, Boonen A, Miedema H, van der Linden S . Employment perspectives of patients with ankylosing spondylitis. Ann Rheum Dis. 2002; 61(8):693-9. PMC: 1754179. DOI: 10.1136/ard.61.8.693. View

Ward M . Predictors of the progression of functional disability in patients with ankylosing spondylitis. J Rheumatol. 2002; 29(7):1420-5. View

Doran M, Brophy S, MacKay K, Taylor G, Calin A . Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol. 2003; 30(2):316-20. View

Gabriel S . The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 2001; 27(2):269-81. DOI: 10.1016/s0889-857x(05)70201-5. View

Boonen A, de Vet H, van der Heijde D, van der Linden S . Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review. J Rheumatol. 2001; 28(5):1056-62. View

10.

Ward M, Kuzis S . Risk factors for work disability in patients with ankylosing spondylitis. J Rheumatol. 2001; 28(2):315-21. View

11.

Uhrin Z, Kuzis S, Ward M . Exercise and changes in health status in patients with ankylosing spondylitis. Arch Intern Med. 2000; 160(19):2969-75. DOI: 10.1001/archinte.160.19.2969. View

12.

Zink A, Braun J, Listing J, Wollenhaupt J . Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol. 2000; 27(3):613-22. View

13.

Haywood K, Garratt A, Dawes P . Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology (Oxford). 2005; 44(5):577-86. DOI: 10.1093/rheumatology/keh549. View

14.

Ward M . Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res. 2000; 12(4):247-55. View

15.

Boonen A, van der Heijde D, Landewe R, Guillemin F, Spoorenberg A, Schouten H . Costs of ankylosing spondylitis in three European countries: the patient's perspective. Ann Rheum Dis. 2003; 62(8):741-7. PMC: 1754633. DOI: 10.1136/ard.62.8.741. View

16.

Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F . Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum. 2003; 49(4):483-7. DOI: 10.1002/art.11197. View

17.

Falkenbach A, Franke A, van der Linden S . Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol. 2003; 30(10):2186-92. View

18.

Zhang G, Luo J, Bruckel J, Weisman M, Schumacher H, Khan M . Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum. 2004; 50(7):2246-54. DOI: 10.1002/art.20308. View

19.

Goie The H, Steven M, van der Linden S, Cats A . Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol. 1985; 24(3):242-9. DOI: 10.1093/rheumatology/24.3.242. View

20.

Wordsworth B, Mowat A . A review of 100 patients with ankylosing spondylitis with particular reference to socio-economic effects. Br J Rheumatol. 1986; 25(2):175-80. DOI: 10.1093/rheumatology/25.2.175. View